Prognostic implication of serum hepatocyte growth factor in stage II/III breast cancer patients who received neoadjuvant chemotherapy.
Kim H, Youk J, Yang Y, Kim TY, Min A, Ham HS, Cho S, Lee KH, Keam B, Han SW, Oh DY, Ryu HS, Han W, Park IA, Kim TY, Noh DY, Im SA.
Kim H, et al. Among authors: ham hs.
J Cancer Res Clin Oncol. 2016 Mar;142(3):707-14. doi: 10.1007/s00432-015-2072-5. Epub 2015 Nov 18.
J Cancer Res Clin Oncol. 2016.
PMID: 26577828